PCDHGA8 Activators would comprise a class of compounds that specifically increase the activity of the protein encoded by the PCDHGA8 gene, which is a member of the protocadherin alpha gene cluster, a group of closely related genes that encode proteins involved in cell-adhesion. These protocadherins are crucial for the establishment and maintenance of specific cell-cell connections in the nervous system. Activators for PCDHGA8 would interact with the protein to promote its adhesive capabilities, possibly by enhancing its ability to bind to other cell surface proteins, by stabilizing its expression on the cell surface, or by modulating signaling pathways that are essential for its function. The molecules that belong to this class would need to be highly specific to the PCDHGA8 protein to avoid off-target effects and might encompass a variety of structural motifs capable of engaging with different parts of the protein, such as its extracellular cadherin repeats, which mediate homophilic binding interactions.
The development of such PCDHGA8 Activators would involve a multi-faceted approach incorporating extensive biochemical and structural research. Initially, a comprehensive understanding of the PCDHGA8 protein's structure, particularly its extracellular domain, would be necessary since this is the region typically involved in cell adhesion functions. Advanced computational modeling might be used to predict potential binding sites for small molecules or peptides on the protein's surface. Once potential binding sites are identified, a combination of chemical synthesis and high-throughput screening could be employed to identify lead compounds capable of interacting with PCDHGA8. These compounds would then be optimized through iterative cycles of design, synthesis, and testing to enhance their selectivity and potency. Biophysical assays, including surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC), would be instrumental in characterizing the binding affinity and kinetics of these activators to PCDHGA8. Furthermore, structural studies using methods such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, or cryo-electron microscopy could provide detailed insights into how these activators bind and modulate the protein. Through these techniques, the precise interaction between PCDHGA8 Activators and the PCDHGA8 protein could be elucidated, shedding light on the molecular mechanisms by which these compounds enhance the protein's activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
As a histone deacetylase inhibitor, it may increase histone acetylation and potentially enhance PCDHGA8 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Could demethylate DNA, possibly leading to the activation of PCDHGA8 gene transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Another histone deacetylase inhibitor potentially increasing transcription of genes like PCDHGA8. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
May regulate gene expression through estrogen receptor signaling, potentially affecting PCDHGA8 expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Known for its epigenetic modulation effects, it could potentially change PCDHGA8 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Could affect gene expression via retinoic acid receptors and may influence PCDHGA8 transcription. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Its active metabolite modulates gene expression through the vitamin D receptor, which could affect PCDHGA8 expression. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
DNA methyltransferase inhibitor that could potentially enhance the expression of PCDHGA8 by hypomethylation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
May increase acetylation of histones near the PCDHGA8 locus and upregulate its expression. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
Mimics cAMP and could activate PKA signaling, potentially influencing PCDHGA8 transcription. | ||||||